Yanwen Jiang
Yanwen Jiang
Instructor, Weill Cornell Medical College of Cornell University
Verified email at
Cited by
Cited by
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
W Béguelin, R Popovic, M Teater, Y Jiang, KL Bunting, M Rosen, H Shen, ...
Cancer cell 23 (5), 677-692, 2013
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
A Ortega-Molina, IW Boss, A Canela, H Pan, Y Jiang, C Zhao, M Jiang, ...
Nature medicine 21 (10), 1199-1208, 2015
Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
H Tilly, F Morschhauser, LH Sehn, JW Friedberg, M Trněný, JP Sharman, ...
New England Journal of Medicine 386 (4), 351-363, 2022
Fixed duration of venetoclax-rituximab in relapsed/refractory chronic lymphocytic leukemia eradicates minimal residual disease and prolongs survival: post-treatment follow-up …
AP Kater, JF Seymour, P Hillmen, B Eichhorst, AW Langerak, C Owen, ...
Journal of Clinical Oncology 34 (4), 269-277, 2019
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ...
Cancer discovery 7 (1), 38-53, 2017
The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation
L Wang, A Gural, XJ Sun, X Zhao, F Perna, G Huang, MA Hatlen, L Vu, ...
Science 333 (6043), 765-769, 2011
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation
R Popovic, E Martinez-Garcia, EG Giannopoulou, Q Zhang, Q Zhang, ...
PLoS genetics 10 (9), e1004566, 2014
Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein
BP Nathan, Y Jiang, GK Wong, F Shen, GJ Brewer, RG Struble
Brain research 928 (1-2), 96-105, 2002
Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study
AP Kater, JQ Wu, T Kipps, B Eichhorst, P Hillmen, J D’rozario, S Assouline, ...
Journal of Clinical Oncology 38 (34), 4042, 2020
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters
K Hatzi, Y Jiang, C Huang, F Garrett-Bakelman, MD Gearhart, ...
Cell reports 4 (3), 578-588, 2013
A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
XJ Sun, Z Wang, L Wang, Y Jiang, N Kost, TD Soong, WY Chen, Z Tang, ...
Nature 500 (7460), 93-97, 2013
Multi-tiered reorganization of the genome during B cell affinity maturation anchored by a germinal center-specific locus control region
KL Bunting, TD Soong, R Singh, Y Jiang, W Béguelin, DW Poloway, ...
Immunity 45 (3), 497-512, 2016
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity
S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ...
PLoS genetics 9 (1), e1003137, 2013
Epigenomic evolution in diffuse large B-cell lymphomas
H Pan, Y Jiang, M Boi, F Tabbò, D Redmond, K Nie, M Ladetto, ...
Nature communications 6, 2015
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax
E Tausch, C Schneider, S Robrecht, C Zhang, A Dolnik, J Bloehdorn, ...
Blood, The Journal of the American Society of Hematology 135 (26), 2402-2412, 2020
Deep-sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
Y Jiang, D Redmond, K Nie, KW Eng, T Clozel, P Martin, LHC Tan, ...
Genome biology 15 (8), 432, 2014
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
F Morschhauser, P Feugier, IW Flinn, R Gasiorowski, R Greil, Á Illés, ...
Blood, The Journal of the American Society of Hematology 137 (5), 600-609, 2021
The role of late/slow replication of the FRA16D in common fragile site induction
A Palakodeti, Y Han, Y Jiang, MM Le Beau
Genes, Chromosomes and Cancer 39 (1), 71-76, 2004
Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study
O Al-Sawaf, C Zhang, T Lu, MZ Liao, A Panchal, S Robrecht, T Ching, ...
Journal of Clinical Oncology 39 (36), 4049, 2021
High‐throughput mapping of origins of replication in human cells
I Lucas, A Palakodeti, Y Jiang, DJ Young, N Jiang, AA Fernald, ...
EMBO reports 8 (8), 770-777, 2007
The system can't perform the operation now. Try again later.
Articles 1–20